← Leaderboards
Robert Sidney Rosenson
Icahn School Of Medicine At Mount Sinai
$2,516,907
Attributed
$2,516,907
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $757.6K · FY2019–22$1M$750K$500K$250K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$2,516,907 · 1
By mechanism
R01$2,516,907 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Alison M Goate$50,419,418
- Girish Nitin Nadkarni$10,989,187
- Nikolaos Robakis$22,366,852
- Stephen R Salton$16,387,402
- Jean-Vianney Haure-Mirande$338,209
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposAbeta SynthesisAstrocytesAfrican AmericanAdultAgedAffectAmericanAmyloidAmyloid Beta-ProteinApolipoprotein A-IApolipoprotein A-IiApolipoprotein EAppointmentActivities Of Daily LivingBaseBrainCase-Control StudiesCell Adhesion MoleculesCerebrospinal FluidCholesterolChronicClinical ResearchCognitive
Grant awards (4)
Use of High Density Lipoprotein Proteome in the Prediction of Cognitive Impairment and Alzheimer's Disease: (REGARDS)$540,619
R01 · FY2022 · AG · contact PI
Use of High Density Lipoprotein Proteome in the Prediction of Cognitive Impairment and Alzheimer's Disease: (REGARDS)$532,144
R01 · FY2021 · AG · contact PI
Use of High Density Lipoprotein Proteome in the Prediction of Cognitive Impairment and Alzheimer's Disease: (REGARDS)$686,541
R01 · FY2020 · AG · contact PI
Use of High Density Lipoprotein Proteome in the Prediction of Cognitive Impairment and Alzheimer's Disease: (REGARDS)$757,603
R01 · FY2019 · AG · contact PI